Navigation Links
Methadone treatment suppresses testosterone in opioid addicts
Date:8/26/2014

HAMILTON, ON (Aug. 26, 2014) Treatment for opioid addiction tampers with the testosterone levels of male but not female opioid users, McMaster University research has shown.

In a paper published today by the journal Scientific Reports, the researchers say addiction treatment may need to change to address the side-effect.

The study found men using methadone, which is used for opioid addiction treatment, have significantly suppressed testosterone levels of about a quarter of the testosterone of men not using opioids. In women using methadone for addiction treatment, testosterone levels were not significantly impacted, even considering the menstrual cycle.

Low testosterone in men has been associated with poor quality of life as well as erectile dysfunction, fatigue, and mood disturbances.

"We expect that treating testosterone deficiency will improve outcomes of methadone treatment for patients, including treatment response and retention," said Dr. Zena Samaan, principal investigator of the study.

"Doctors should also ensure the patients are being prescribed the lowest dose of opioids including methadone for effective treatment to minimize testosterone suppression."

She added that this is a particular issue in Canada, the second largest consumer of opioids in the world.

Dr. Samaan is an associate professor of the psychiatry and behavioural neurosciences department of McMaster's Michael G. DeGroote School of Medicine.

The study involved information from 231 patients with opioid dependence receiving methadone in Ontario, as well as 783 Ontarians not using opioids. It was funded by the Drug Safety and Effectiveness Network of the Canadian Institutes of Health Research and the McMaster Department of Psychiatry and Behavioural Neurosciences. The study was conducted by the Population Genomics Program of McMaster's Chanchlani Research Centre, and Ontario Addiction Treatment Centres.


'/>"/>

Contact: Veronica McGuire
vmcguir@mcmaster.ca
90-552-591-402-2169
McMaster University
Source:Eurekalert

Related medicine news :

1. Methadone programs can be key in educating, treating HCV patients
2. Long-term methadone treatment can affect nerve cells in brain
3. Testosterone Therapy Lawsuits: AndroGel Manufacturer Files Petition Against FDA's Decision on Generic Testosterone Treatment Drug
4. Millennium Treatment Group Sees Decline in DUI Rates
5. Testosterone Treatment Lawsuit News: Federal Court OverseeingTestosterone Litigation Convenes Conference to Discuss Pretrial Management, Bernstein Liebhard LLP Reports
6. Backs in Action Wellness Center Now Provides Specialized Pregnancy Back Pain Treatment
7. Increasing Demand for Skin Resurfacing Treatments: U.S. Fractional Laser Systems Market Led by Valeant, Lumenis and Syneron
8. University Of Iowa Celebrates The Dedication Of The Fraternal Order Of Eagles Diabetes Research Center - 100 Researchers Help Identify New Treatments & Cures For Diabetes
9. Diet Doc’s Medical Weight Loss Programs Announces the Best Diet for Fast Weight Loss with Hormone Treatments and Tailor Made Diet Plans
10. Diagnosing Balance Disorders Improves Treatment Outcomes for Patients Experiencing Dizziness, Vertigo
11. Millennium Treatment Group Sees Increase in Marijuana Use Among Youth
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/28/2017)... Suffern, NY (PRWEB) , ... March 28, 2017 ... ... and process management software and services, is proud to announce it has joined ... respected professional association representing the interests of chronically ill, disabled, and dying Americans ...
(Date:3/28/2017)... , ... March 28, 2017 , ... ... today that the University of Pittsburgh Medical Center (UPMC) will acquire QuikClot® Bleeding ... Pennsylvania. , The program, developed in association with efforts by the American College ...
(Date:3/28/2017)... ... March 28, 2017 , ... Calibration, qualification, and the ... results and maintaining GMP and USP compliance. In a new webinar from METTLER ... requirements " these requirements are explained. The challenge is to determine how ...
(Date:3/28/2017)... ... 28, 2017 , ... With less than 10,000 dermatologists in the United States ... be limited while the desire to conquer breakouts and eliminate skincare stress is widespread. ... customer online, today released its inaugural survey on the State of Acne in America. ...
(Date:3/28/2017)... ... March 28, 2017 , ... Columbus OH. Dr. Justin Harper, Founder of ... medical professionals in the country to sit on the 2017 National Advisory Board for ... 2 years Dr. Harper helped propel the clinic from a small start-up to number ...
Breaking Medicine News(10 mins):
(Date:3/28/2017)... and TORONTO , March ... leading full service medical device development firm, ... the visionary Toronto -based medical device ... will better serve medtech companies throughout North ... resources and experienced medical device talent spanning the design, ...
(Date:3/28/2017)... and TEL AVIV, Israel , March ... subsidiary in Israel . This new business entity, ... be mostly dedicated to research and development of novel assays complementing ... will also, when relevant, locally support commercialization and sales development of ... This ...
(Date:3/28/2017)... , March 28, 2017 RXi Pharmaceuticals ... innovative therapeutics that address significant unmet medical needs, ... from the Japan Patent Office (JPO) for the ... growth factor (CTGF) for the treatment or prevention ... skin fibrosis and proliferative retinopathy (Japanese Patent #: ...
Breaking Medicine Technology: